Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys
Authors
Keywords
-
Journal
PSYCHOPHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-01
DOI
10.1007/s00213-018-5089-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GLP-1 signaling and alcohol-mediated behaviors; preclinical and clinical evidence
- (2018) Elisabet Jerlhag NEUROPHARMACOLOGY
- Medications for alcohol use disorders: An overview
- (2018) Mohammed Akbar et al. PHARMACOLOGY & THERAPEUTICS
- The glucagon-like peptide 1 receptor agonist Exendin-4 decreases relapse-like drinking in socially housed mice
- (2017) Morgane Thomsen et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models
- (2016) Megan M. Yardley et al. ADDICTION BIOLOGY
- Effects of the GLP-1 Agonist Exendin-4 on Intravenous Ethanol Self-Administration in Mice
- (2016) Gunnar Sørensen et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Decreased Hypothalamic Glucagon-Like Peptide-1 Receptor Expression in Type 2 Diabetes Patients
- (2016) Jennifer S. ten Kulve et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Alcohol use disorders
- (2016) Jason P Connor et al. LANCET
- Central & peripheral glucagon-like peptide-1 receptor signaling differentially regulate addictive behaviors
- (2016) Sunil Sirohi et al. PHYSIOLOGY & BEHAVIOR
- The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents
- (2015) Daniel Vallöf et al. ADDICTION BIOLOGY
- Chronic Continuous Exenatide Infusion Does Not Cause Pancreatic Inflammation and Ductal Hyperplasia in Non-Human Primates
- (2015) Teresa Vanessa Fiorentino et al. AMERICAN JOURNAL OF PATHOLOGY
- Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics
- (2015) Lisbeth V. Jacobsen et al. CLINICAL PHARMACOKINETICS
- Exenatide Extended-Release: An Updated Review of Its Use in Type 2 Diabetes Mellitus
- (2015) Yahiya Y. Syed et al. DRUGS
- Expression and Distribution of Glucagon-Like Peptide-1 Receptor mRNA, Protein and Binding in the Male Nonhuman Primate (Macaca mulatta) Brain
- (2015) Kristy M. Heppner et al. ENDOCRINOLOGY
- Incretin actions and consequences of incretin-based therapies: lessons from complementary animal models
- (2015) Simone Renner et al. JOURNAL OF PATHOLOGY
- The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: evidence from human genetic association studies and a mouse model of alcohol dependence
- (2015) P Suchankova et al. Translational Psychiatry
- Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain
- (2015) Simon C. Cork et al. Molecular Metabolism
- The Human GLP-1 Analogs Liraglutide and Semaglutide: Absence of Histopathological Effects on the Pancreas in Nonhuman Primates
- (2014) C. F. Gotfredsen et al. DIABETES
- The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
- (2014) Anna Secher et al. JOURNAL OF CLINICAL INVESTIGATION
- Endogenous Glucagon-Like Peptide-1 Reduces Drinking Behavior and Is Differentially Engaged by Water and Food Intakes in Rats
- (2014) Naomi J. McKay et al. JOURNAL OF NEUROSCIENCE
- The Economic Burden of Alcohol Dependence in Europe
- (2013) P. Laramee et al. ALCOHOL AND ALCOHOLISM
- The Declining Efficacy of Naltrexone Pharmacotherapy for Alcohol Use Disorders Over Time: A Multivariate Meta-Analysis
- (2013) A. C. Del Re et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
- (2012) Kerry Hunter et al. BMC NEUROSCIENCE
- The Human GLP-1 Analog Liraglutide and the Pancreas
- (2012) Niels C.B. Nyborg et al. DIABETES
- Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment
- (2012) M. S. Fineman et al. DIABETES OBESITY & METABOLISM
- The Glucagon-Like Peptide 1 (GLP-1) Analogue, Exendin-4, Decreases the Rewarding Value of Food: A New Role for Mesolimbic GLP-1 Receptors
- (2012) S. L. Dickson et al. JOURNAL OF NEUROSCIENCE
- The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents
- (2012) Emil Egecioglu et al. PSYCHONEUROENDOCRINOLOGY
- GLP-1 Neurons in the Nucleus of the Solitary Tract Project Directly to the Ventral Tegmental Area and Nucleus Accumbens to Control for Food Intake
- (2011) Amber L. Alhadeff et al. ENDOCRINOLOGY
- Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction
- (2011) Jacob Lønborg et al. EUROPEAN HEART JOURNAL
- Liraglutide Treatment Is Associated with a Low Frequency and Magnitude of Antibody Formation with No Apparent Impact on Glycemic Response or Increased Frequency of Adverse Events: Results from the Liraglutide Effect and Action in Diabetes (LEAD) Trials
- (2011) John B. Buse et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pharmacokinetics and Pharmacodynamics of Exenatide Extended-Release After Single and Multiple Dosing
- (2010) Mark Fineman et al. CLINICAL PHARMACOKINETICS
- Transferrin Fusion Technology: A Novel Approach to Prolonging Biological Half-Life of Insulinotropic Peptides
- (2010) B.-J. Kim et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation